We are live on ! Find out more
THRN

Thorne Healthtech, Inc. Common Stock

Delisted

THRN was delisted on the 13th of October, 2023.

0 hedge funds and large institutions have $0 invested in Thorne Healthtech, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 59 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 590 (-59)

100% less capital invested

Capital invested by funds: $82.9M → $0 (-$82.9M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 59

Holders
Holders Change
-59
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
59
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TRCT
51
Tower Research Capital (TRC)
New York
-$13.8K -1,351 Closed
Legal & General Group
52
Legal & General Group
United Kingdom
-$13.5K -1,325 Closed
Fidelity Investments
53
Fidelity Investments
Massachusetts
-$12.8K -1,261 Closed
MLICM
54
Metropolitan Life Insurance Company (MetLife)
New York
-$9.23K -906 Closed
Russell Investments Group
55
Russell Investments Group
United Kingdom
-$4.71K -462 Closed
C
56
Covestor
United Kingdom
-$2K -201 Closed
Citigroup
57
Citigroup
New York
-$153 -15 Closed
MCM
58
Manchester Capital Management
Vermont
-$102 -10 Closed

THRN Hedge Fund Activity: Q4 2023 in Review

0 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Thorne Healthtech, Inc. Common Stock (THRN) for Q4 2023, worth a combined $0 — down 100% from $82.9M a quarter earlier.

Sellers outnumbered buyers: 59 funds closed out of THRN and 0 opened new positions — a net loss of 59 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Glazer Capital LLC, exiting entirely with an estimated $13.6M sold.

  • 0 institutional investors held Thorne Healthtech, Inc. Common Stock (THRN) as of Q4 2023, down from 59 in Q3 2023.
  • Funds reported $0 of Thorne Healthtech, Inc. Common Stock stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Thorne Healthtech, Inc. Common Stock positions in Q4 2023 and 59 closed out, a net change of -59 holders.
  • The largest Thorne Healthtech, Inc. Common Stock seller in Q4 2023 was Glazer Capital LLC, an estimated $13.6M sold.

Based on aggregated 13F filings for Q4 2023.